zonisamide
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
23
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Partial, Generalized and Combined Seizures
Conditions
Partial, Generalized and Combined Seizures
Trial Timeline
Jan 1, 2011 → May 1, 2013
NCT ID
NCT01283256About zonisamide
zonisamide is a pre-clinical stage product being developed by Eisai for Partial, Generalized and Combined Seizures. The current trial status is completed. This product is registered under clinical trial identifier NCT01283256. Target conditions include Partial, Generalized and Combined Seizures.
Hype Score Breakdown
Clinical
5
Activity
2
Company
10
Novelty
2
Community
1
Clinical Trials (6)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01283256 | Pre-clinical | Completed |
| NCT01136954 | Phase 3 | Completed |
| NCT00659958 | Approved | Completed |
| NCT01140867 | Approved | Completed |
| NCT00259636 | Approved | Withdrawn |
| NCT00056576 | Phase 3 | Completed |
Competing Products
20 competing products in Partial, Generalized and Combined Seizures
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| E2007 | Eisai | Phase 3 | 77 |
| Perampanel | Eisai | Pre-clinical | 23 |
| perampanel + perampanel | Eisai | Phase 1 | 33 |
| perampanel + perampanel + perampanel + Placebo | Eisai | Phase 3 | 77 |
| Perampanel + Placebo | Eisai | Approved | 85 |
| Perampanel and Microgynon-30 + Perampanel and Microgynon-30 | Eisai | Phase 1 | 33 |
| perampanel | Eisai | Phase 2 | 52 |
| Perampanel | Eisai | Pre-clinical | 23 |
| Zonisamide + Placebo | Eisai | Phase 3 | 77 |
| E2007 (perampanel) + E2007 (perampanel) + Placebo | Eisai | Phase 3 | 77 |
| Perampanel + Placebo | Eisai | Phase 3 | 77 |
| E2007 (perampanel) + E2007 (perampanel) + Placebo | Eisai | Phase 3 | 77 |
| Adjunctive Zonisamide + Replacement with Zonisamide | Eisai | Approved | 85 |
| Fycompa | Eisai | Pre-clinical | 23 |
| Zonisamide + Placebo | Eisai | Phase 3 | 77 |
| Fycompa | Eisai | Pre-clinical | 23 |
| Rufinamide | Eisai | Phase 3 | 77 |
| Zonisamide | Eisai | Phase 3 | 77 |
| Eslicarbazepine Acetate tablets | Eisai | Pre-clinical | 23 |
| Perampanel | Eisai | Pre-clinical | 23 |